-
My Account
co-presented by
ASSOCIATE SPONSORS
In App
My Account
co-presented by
ASSOCIATE SPONSORS
co-presented by
ASSOCIATE SPONSORS
BSE Live
Nov 05, 16:00Prev. Close
0.77
Open Price
0.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.77 (38071)
NSE Live
Nov 05, 15:32Prev. Close
0.70
Open Price
0.65
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Sterling Biotech (in Rs. Cr.) | Mar 18 | Mar 17 | Mar 16 | Dec 14 | Dec 13 | |
| 12 mths | 12 mths | 15 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 0.00 | -616.80 | -687.62 | -631.16 | -593.08 | |
| Net CashFlow From Operating Activities | 0.00 | 0.95 | 67.03 | 255.89 | 171.87 | |
| Net Cash Used In Investing Activities | 0.00 | -49.28 | -84.45 | 17.20 | -314.82 | |
| Net Cash Used From Financing Activities | 0.00 | 48.62 | 16.40 | -272.92 | 142.60 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.00 | 0.29 | -1.02 | 0.17 | -0.35 | |
| Cash And Cash Equivalents Begin of Year | 0.00 | 16.64 | 17.66 | 17.49 | 17.83 | |
| Cash And Cash Equivalents End Of Year | 0.00 | 16.93 | 16.64 | 17.66 | 17.49 |
17.09.2024
Zydus Lifesciences board approves acquisition of API business of Sterling Biotech for Rs 84 crore
30.08.2022
Five promoters who siphoned funds overseas, defrauded Indian banks
29.09.2020
Court declares Sterling Biotech promoters 'fugitive economic offenders'
28.08.2019
Sterling Biotech case: ED records statement of Ahmed Patel's son Faisal
